Home » World Health Organization (WHO) » Page 2

World Health Organization (WHO)

Side event: Innovative responses to promoting access to controlled medicines while preventing diversion and non-medical use: following up on the global “Access and Availability campaign by the chair of the 65th Commission on Narcotic Drugs”

Ambassador Vermuelen (Belgium): introduced the topic and the history of Belgium’s involvement including last year’s initiative, which was at the heart of Belgium’s Presidency of CND. Speakers: Dilkushi Poovendran (WHO), Ghislain D’Hoop, Carolyn Patterson (Assistant Secy Govt of Australia, Health and Aged Care) Jagit Pavadia, President, INCB: Thank you to the govt of Belgium and …

Read more

Side Event: Gender and drug overdose – trends and evidence for improved responses and drug policies

Organised by Sweden with the support of Canada, Norway, the UNODC Prevention, Treatment and Rehabilitation Section, the World Health Organisation, the European Union and its Member States, and the Pompidou Group of the Council of Europe Moderator: Annika Markovic, Ambassdor, Sweden. I have the privilege of representing the UN International Organizations in Vienna. The topic …

Read more

CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022

Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem”  The provisional agenda for the intersessional meeting is as follows: 1. Thematic …

Read more